Evidence map›Paper›PMID 34577549›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Catenin Alpha 2 May Be a Biomarker or Potential Drug Target in Psychiatric Disorders with Perseverative Negative Thinking.

Nora Eszlari, Zsolt Bagyura, Andras Millinghoffer, Tamas Nagy, Gabriella Juhasz, Peter Antal, Bela Merkely, Gyorgy Bagdy

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nora EszlariDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, Hungary.ORCID 0000-0003-4913-028X
Zsolt BagyuraHeart and Vascular Center, Semmelweis University, Városmajor utca 68, H-1122 Budapest, Hungary.ORCID 0000-0001-8120-2322
Andras MillinghofferNAP-2-SE New Antidepressant Target Research Group, Hungarian Brain Research Program, Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, Hungary.
Tamas NagyDepartment of Measurement and Information Systems, Budapest University of Technology and Economics, Magyar Tudósok krt. 2, H-1521 Budapest, Hungary.ORCID 0000-0002-0137-4341
Gabriella JuhaszDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, Hungary.ORCID 0000-0002-5975-4267
Peter AntalDepartment of Measurement and Information Systems, Budapest University of Technology and Economics, Magyar Tudósok krt. 2, H-1521 Budapest, Hungary.
Bela MerkelyHeart and Vascular Center, Semmelweis University, Városmajor utca 68, H-1122 Budapest, Hungary.
Gyorgy BagdyDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, Hungary.
Semmelweis University · HUBudapest University of Technology and Economics · HU

Funding

Hungarian Brain Research Program 2017-1.2.1-NKP-2017-00002Hungarian Brain Research Program KTIA_13_NAPA-II/14Hungarian Scientific Research Fund OTKA 119866Magyar Tudományos Akadémia KTIA_NAP_13-2-2015-0001National Research, Development and Innovation Office 2019-2.1.7-ERA-NET-2020-00005National Research, Development and Innovation Office NVKP-16-1-2016-0017Nemzeti Fejlesztési Ügynökség KTIA_NAP_13-1-2013-0001Nemzeti Kutatási, Fejlesztési és Innovaciós Alap BME-IE-BIONemzeti Kutatási, Fejlesztési és Innovaciós Alap ÚNKP-20-4-II-SE-9Thematic Excellence Programme 2020-4.1.1.-TKP2020
6 · The paper itself

Abstract

AlphaN-catenin gene

Indexed as

body mass indexBrief Symptom Inventorycatenin alpha 2CTNNA2Framingham Risk Scoreperseverative cognitionpsychiatric symptomsrumination

Identifiers

PMID34577549
PMCPMC8468481
OpenAlexW3193367269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.